Frankfurt - Delayed Quote EUR

Zimmer Biomet Holdings, Inc. (ZIM.F)

90.02
+1.00
+(1.12%)
As of 8:10:12 AM GMT+2. Market Open.

Research Analysis

Revenue vs. Earnings

Revenue 2.02B
Earnings 462.4M

Q1'24

Q2'24

Q3'24

Q4'24

0
500M
1B
2B
2B
 

Analyst Price Targets

Earnings Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts --------
Avg. Estimate 0000
Low Estimate 0000
High Estimate 0000
Year Ago EPS --------

Revenue Estimate

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 23212725
Avg. Estimate 1.9B1.99B7.9B8.27B
Low Estimate 1.88B1.95B7.82B8.12B
High Estimate 1.93B2.05B8.05B8.58B
Year Ago Sales 1.89B1.94B7.68B7.9B
Sales Growth (year/est) 0.32%2.35%2.93%4.69%

EPS Trend

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate 0000
7 Days Ago 0000
30 Days Ago 0000
60 Days Ago 0000
90 Days Ago 0000

EPS Revisions

Currency in USD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
ZIM.F --------
S&P 500 9.62%4.20%8.36%13.90%

Upgrades & Downgrades

Reiterates Truist Securities: Hold to Hold 2/10/2025
Maintains Barclays: Underweight to Underweight 2/10/2025
Maintains RBC Capital: Outperform to Outperform 2/7/2025
Maintains Raymond James: Outperform to Outperform 2/7/2025
Reiterates JMP Securities: Market Outperform to Market Outperform 2/7/2025
Reiterates Needham: Hold to Hold 2/7/2025